Step 1 topics → General Pathology → Acute Phase Response

Acute Phase Response

USMLE Step 1 trap: Confuses CRP and ESR kinetics as interchangeable acute phase markers. CRP rises and falls faster than ESR, making CRP more useful for monitoring acute changes, while ESR reflects fibrinogen levels and lags behind.

The acute phase response is tested on USMLE Step 1 both as direct recall (which proteins go up vs. down?) and as clinical application — a classic trap is albumin, which students expect to rise with inflammation but is actually a negative acute phase reactant. The liver's coordinated response is driven by cytokines (primarily IL-1, IL-6, and TNF-α) released from activated macrophages, shifting protein synthesis toward positive reactants (CRP, fibrinogen, hepcidin, serum amyloid A) and away from albumin and transferrin.

The exam hits several angles here. The most straightforward is identifying positive vs. negative acute phase reactants — and albumin is the classic trap. Students also get tested on the mechanistic pathway from chronic inflammation to anemia of chronic disease, which requires knowing the hepcidin-ferroportin axis specifically, not just vaguely knowing 'inflammation causes anemia.' The CRP vs. ESR distinction comes up in vignettes asking which marker you'd use to monitor treatment response. And the SAA-to-AA amyloidosis connection rewards students who understand the downstream consequences of sustained acute phase activation.

What makes this topic tricky is that the connections span multiple systems. You need to link cytokines → hepatic protein synthesis → iron metabolism → hematology, and separately link chronic inflammation → SAA elevation → amyloid deposition → organ dysfunction. Students who memorize isolated facts without building these chains get fooled by Step 1 vignettes that ask about the endpoint (e.g., nephrotic syndrome from amyloid) and require working backward to the inflammatory cause.

From real student decks
65%have cards covering this topic
49%have mature cards

Common misconceptions

Common mistake
Wrong: ESR and CRP are equivalent acute phase markers with the same kinetics.
Right: CRP rises and falls faster than ESR, making CRP more useful for monitoring acute changes, while ESR reflects fibrinogen levels and lags behind.
CRP and ESR both rise in inflammation, but their kinetics are completely different and this distinction is clinically tested. CRP is directly synthesized by the liver in response to IL-6 and rises within hours, then falls within days once inflammation resolves — making it the preferred marker for monitoring acute changes or treatment response. ESR is an indirect measurement that reflects how quickly RBCs sediment, which is largely driven by fibrinogen levels; because fibrinogen itself takes longer to rise and fall, ESR lags behind by days to weeks. On the exam, if a vignette asks which marker better reflects current disease activity or responds faster to treatment, the answer is CRP.
Common mistake
Wrong: Albumin is a positive acute phase reactant that increases during inflammation.
Right: Albumin is a negative acute phase reactant that decreases during inflammation as the liver prioritizes synthesis of positive reactants.
Albumin is a negative acute phase reactant — it decreases during inflammation — which is the opposite of what students often assume given albumin's importance as a major plasma protein. The reasoning is a metabolic trade-off: when IL-1, IL-6, and TNF-α signal the liver to mount an acute phase response, the liver reprioritizes its synthetic machinery toward producing positive reactants like CRP, fibrinogen, and complement proteins. Albumin synthesis is correspondingly downregulated. Clinically, a low albumin in the setting of chronic illness is not primarily about malnutrition — it is often a marker of ongoing inflammatory activity. Transferrin is also a negative reactant, which matters for understanding the iron panel in anemia of chronic disease.
Common mistake
Wrong: Anemia of chronic disease results from blood loss or hemolysis caused by inflammation.
Right: Hepcidin, induced by IL-6, blocks ferroportin on macrophages and enterocytes, trapping iron intracellularly and causing functional iron deficiency despite adequate iron stores.
Anemia of chronic disease is not about losing blood or destroying red cells — it is about sequestering iron so effectively that erythropoiesis becomes iron-limited even when total body iron stores are adequate or elevated. The mechanism: chronic inflammation drives IL-6 production → IL-6 stimulates hepatic hepcidin synthesis → hepcidin binds and degrades ferroportin, the only known cellular iron exporter → iron becomes trapped inside macrophages (which normally recycle iron from old RBCs) and enterocytes (which normally absorb dietary iron) → serum iron drops → erythropoiesis slows. The iron is there; it just can't get out. This explains the classic lab pattern: low serum iron, low TIBC, elevated ferritin, and normal-to-high iron stores on bone marrow biopsy.
Common mistake
Wrong: AA amyloidosis derives from immunoglobulin light chains like AL amyloidosis.
Right: AA amyloidosis derives from serum amyloid A (SAA), an acute phase reactant chronically elevated in persistent inflammation, which is distinct from the immunoglobulin-derived AL type.
AA and AL amyloidosis are both systemic amyloid diseases, but their precursor proteins are completely different and so are their clinical triggers. AL amyloidosis derives from immunoglobulin light chains and is associated with plasma cell dyscrasias like multiple myeloma. AA amyloidosis derives from serum amyloid A (SAA), a positive acute phase reactant that is chronically elevated in conditions with sustained inflammation — think rheumatoid arthritis, chronic osteomyelitis, inflammatory bowel disease, or familial Mediterranean fever. When SAA stays elevated for years, it gradually deposits in organs (especially the kidney, liver, and spleen) as amyloid fibrils. The clinical red flag is a patient with long-standing inflammatory disease who develops nephrotic syndrome or unexplained organomegaly — that's AA amyloidosis until proven otherwise.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which cytokines (IL-1, IL-6, TNF-α) drive the hepatic acute phase response and which specific proteins the liver upregulates in response — including CRP, fibrinogen, ferritin, hepcidin, serum amyloid A, and complement proteins.
  2. Distinguish positive acute phase reactants (increase with inflammation) from negative ones (decrease with inflammation, including albumin and transferrin), and know why the liver makes this trade-off.
  3. Trace the full hepcidin pathway: IL-6 stimulates hepcidin synthesis → hepcidin degrades ferroportin on macrophages and duodenal enterocytes → iron is trapped intracellularly → functional iron deficiency → microcytic or normocytic anemia despite normal or elevated total body iron stores.
  4. Connect chronic, persistent inflammation to AA amyloidosis via sustained elevation of serum amyloid A (SAA), and distinguish AA amyloidosis (SAA-derived) from AL amyloidosis (immunoglobulin light chain-derived) in terms of precursor protein and clinical setting.

Can you avoid these mistakes?

A patient with rheumatoid arthritis for 12 years develops nephrotic-range proteinuria. Renal biopsy shows Congo red-positive deposits with apple-green birefringence. What is the precursor protein responsible, and what is the mechanistic chain linking the patient's arthritis to this finding?
A patient is being treated for bacterial endocarditis. You want to monitor whether the infection is responding to antibiotics over the next 48-72 hours. Would you follow CRP or ESR, and why?
A patient with Crohn's disease has the following iron studies: low serum iron, low TIBC, elevated ferritin, normal MCV. What cytokine is responsible for this pattern, what protein does it induce, and what is the molecular mechanism producing iron-restricted erythropoiesis?
A 55-year-old woman with active rheumatoid arthritis has a serum albumin of 2.8 g/dL. Her rheumatologist says this reflects inflammatory activity, not malnutrition. From the list CRP, fibrinogen, albumin, serum amyloid A, and transferrin, identify which are positive vs. negative acute phase reactants — and explain the metabolic trade-off that causes the liver to reduce albumin synthesis during acute inflammation.

Related topics

Chemical Mediators of Inflammation Reversible vs Irreversible Cell Injury Types of Necrosis Apoptosis (Intrinsic and Extrinsic Pathways) Cell Adaptations (Atrophy, Hypertrophy, Hyperplasia, Metaplasia, Dysplasia)

See how your Anki deck covers this topic.

Upload your deck for a free audit →